Sanofi R&D Head Zerhouni Says Global Body For Health Care Is Needed
This article was originally published in PharmAsia News
Drug development and regulation needs to be addressed on a world basis by a supranational entity that could be similar to WTO for trade, a Sanofi exec believes.
You may also be interested in...
Former NIH director drafted by Viehbacher in early 2009 to be his science advisor replaces Cluzel as R&D chief.
Evotec’s multimodality approach to drug discovery landed the biotech two new discovery collaborations this week, underscoring its emphasis on patient-driven data.
Novo Nordisk and Evotec will identify and develop novel drugs for treating chronic kidney disease, using datasets of CKD patients provided by the Danish group and from other sources.